GILEAD SCIENCES INC Insider Trading for November 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for November 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Gift | G | 0.00 | 7,050 | 0 | 23,669 | 30.7 K to 23.7 K (-22.95 %) |
| Nov 25 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 106.48 | 169 | 17,995 | 30,719 | 30.9 K to 30.7 K (-0.55 %) |
| Nov 25 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 107.18 | 2,863 | 306,845 | 30,888 | 33.8 K to 30.9 K (-8.48 %) |
| Nov 25 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 106.99 | 5,514 | 589,917 | 33,751 | 39.3 K to 33.8 K (-14.04 %) |
| Nov 25 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 20.71 | 15,000 | 310,575 | 15,000 | |
| Nov 25 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 105.95 | 15,000 | 1,589,190 | 44,309 | 59.3 K to 44.3 K (-25.29 %) |
| Nov 25 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 20.71 | 15,000 | 310,575 | 59,309 | 44.3 K to 59.3 K (+33.85 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.76 | 70,000 | 1,662,850 | 72,400 | |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.79 | 5,544 | 575,396 | 165,168 | 170.7 K to 165.2 K (-3.25 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.26 | 18,981 | 1,959,881 | 170,712 | 189.7 K to 170.7 K (-10.01 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 102.26 | 45,475 | 4,650,142 | 189,693 | 235.2 K to 189.7 K (-19.34 %) |
| Nov 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.76 | 70,000 | 1,662,850 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Nov 13 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 5,000 | 0 | 2,149,681 | 2.2 M to 2.1 M (-0.23 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 2,892 | 0 | 90,938 | 88 K to 90.9 K (+3.28 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 2,892 | 0 | 27,724 | 30.6 K to 27.7 K (-9.45 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 100,000 | |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 108.27 | 8,509 | 921,267 | 1,029,108 | 1 M to 1 M (-0.82 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 107.60 | 91,491 | 9,844,377 | 1,037,617 | 1.1 M to 1 M (-8.10 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Nov 09 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
| Nov 09 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 107.83 | 3,108 | 335,136 | 30,616 | 33.7 K to 30.6 K (-9.22 %) |
| Nov 09 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 0.00 | 6,000 | 0 | 33,724 | 27.7 K to 33.7 K (+21.64 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,816 | 73,657 | 10,255 | |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 184 | 4,966 | 2,823 | |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 108.36 | 2,000 | 216,712 | 48,783 | 50.8 K to 48.8 K (-3.94 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 40.56 | 1,816 | 73,657 | 50,783 | 52.6 K to 50.8 K (-3.45 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | M | 26.99 | 184 | 4,966 | 48,967 | 49.2 K to 49 K (-0.37 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 109.61 | 4,350 | 476,806 | 88,046 | 92.4 K to 88 K (-4.71 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 109.13 | 1,900 | 207,344 | 92,396 | 94.3 K to 92.4 K (-2.01 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 24.30 | 10,000 | 242,950 | 118,742 | |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 109.67 | 5,860 | 642,642 | 131,422 | 137.3 K to 131.4 K (-4.27 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 109.10 | 6,140 | 669,865 | 137,282 | 143.4 K to 137.3 K (-4.28 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 24.30 | 10,000 | 242,950 | 143,422 | 133.4 K to 143.4 K (+7.50 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 150,000 | |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 109.58 | 107,583 | 11,788,827 | 3,948,066 | 4.1 M to 3.9 M (-2.65 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 109.02 | 42,417 | 4,624,200 | 4,055,649 | 4.1 M to 4.1 M (-1.04 %) |
| Nov 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,098,066 | 3.9 M to 4.1 M (+3.80 %) |